Wall Street Analyst Initiated Trevena Inc. [TRVN]. What else is Wall St. saying



Trevena Inc. [NASDAQ: TRVN] stock went on a downward path that fall over -31.82% on Wednesday, amounting to a one-week price decrease of less than -31.27%. The company report on May 11, 2022 that Trevena Reports First Quarter 2022 Results and Provides Business Update.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


OLINVYK refocused commercial strategy initiated mid-Q1.

OLINVYK respiratory physiology study demonstrated statistically significant reduced impact on respiratory function compared to IV morphine, among elderly/overweight subjects.

Over the last 12 months, TRVN stock dropped by -87.03%. The one-year Trevena Inc. stock forecast points to a potential upside of 94.55. The average equity rating for TRVN stock is currently 2.20, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $33.35 million, with 164.74 million shares outstanding and 162.39 million shares in the current float. Compared to the average trading volume of 1.10M shares, TRVN stock reached a trading volume of 3781250 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Trevena Inc. [TRVN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TRVN shares is $3.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TRVN stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Oppenheimer have made an estimate for Trevena Inc. shares, keeping their opinion on the stock as Perform, with their previous recommendation back on March 15, 2021. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on September 14, 2020, representing the official price target for Trevena Inc. stock. Previously, the target price had yet another raise to $5, while Cantor Fitzgerald analysts kept a Overweight rating on TRVN stock.

The Average True Range (ATR) for Trevena Inc. is set at 0.04, with the Price to Sales ratio for TRVN stock in the period of the last 12 months amounting to 55.58. The Price to Book ratio for the last quarter was 0.50, with the Price to Cash per share for the same quarter was set at 0.39.

TRVN Stock Performance Analysis:

Trevena Inc. [TRVN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -31.27. With this latest performance, TRVN shares dropped by -52.36% in over the last four-week period, additionally sinking by -79.46% over the last 6 months – not to mention a drop of -87.03% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TRVN stock in for the last two-week period is set at 25.31, with the RSI for the last a single of trading hit 21.87, and the three-weeks RSI is set at 28.93 for Trevena Inc. [TRVN]. The present Moving Average for the last 50 days of trading for this stock 0.4027, while it was recorded at 0.2510 for the last single week of trading, and 0.7841 for the last 200 days.

Insight into Trevena Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Trevena Inc. [TRVN] shares currently have an operating margin of -9157.85 and a Gross Margin at -216.58. Trevena Inc.’s Net Margin is presently recorded at -9098.41.

Return on Equity for this stock declined to -61.16, with Return on Assets sitting at -49.64.

Trevena Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.40 and a Current Ratio set at 7.70.

Trevena Inc. [TRVN] Insider Position Details

There are presently around $10 million, or 21.50% of TRVN stock, in the hands of institutional investors. The top three institutional holders of TRVN stocks are: BLACKROCK INC. with ownership of 11,139,459, which is approximately 0.097% of the company’s market cap and around 3.00% of the total institutional ownership; VANGUARD GROUP INC, holding 7,823,587 shares of the stock with an approximate value of $2.25 million in TRVN stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.86 million in TRVN stock with ownership of nearly -0.521% of the company’s market capitalization.

Positions in Trevena Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 38 institutional holders increased their position in Trevena Inc. [NASDAQ:TRVN] by around 4,128,031 shares. Additionally, 32 investors decreased positions by around 4,934,238 shares, while 27 investors held positions by with 26,997,880 shares. The mentioned changes placed institutional holdings at 36,060,149 shares, according to the latest SEC report filing. TRVN stock had 13 new institutional investments in for a total of 1,672,276 shares, while 9 institutional investors sold positions of 4,120,944 shares during the same period.